一种胰岛素-染色素混合激活DR11受限T细胞在人类1型糖尿病
Aïsha Callebaut1,2, Perrin Guyer1, Rocky L Baker3
1Center for Translational Immunology, Benaroya Research Institute, Seattle, WA.
Diabetes
|January 31, 2024
概括
混合胰岛素 (HIPs),特别是HIP9 (C--染色素A [CgA] HIP),与人类1型糖尿病自身免疫有关. 在糖尿病患者中发现HIP9反应性T细胞的频率更高,特别是那些具有特定HLA类型的人.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
背景情况:
- 混合胰岛素 (HIP) 是由亲胰岛素碎片和分泌颗粒组成的.
- 称为2.5HIP的C--染色素A (CgA) HIP是非肥胖糖尿病小鼠的一个关键自身抗原.
- 人类1型糖尿病 (T1D) 中HIPs,特别是HIP9的作用在很大程度上仍未被描述.
研究的目的:
- 在1型糖尿病患者中研究T细胞对人类HIP9的反应性.
- 为了确定HIP9反应性T细胞和人类白细胞抗原 (HLA) 类型之间的关联.
- 探索HIP9在β细胞自身免疫的发展中的潜在作用.
主要方法:
- 对HIP9有反应性的新型T细胞克隆的分离和表征.
- 在患有和没有糖尿病的个体中测量HIP9-反应性T细胞的HLAII类四聚体染色.
- 对T细胞响应与特定的HLA单元型和诊断时的年龄相关的分析.
主要成果:
- 一种新型T细胞克隆对HIP9产生了强烈的反应,相当于人类的2.5HIP.
- 与对照人群相比,在1型糖尿病患者中观察到HIP9反应性T细胞的频率更高.
- 在特定的HLA环境中 (DR11+和DRB4+),HIP9反应T细胞的频率超过了亲胰岛素9-28表位的频率.
- 在HIP9反应T细胞频率和诊断时的年龄之间发现了负相关性.
结论:
- 提供了关于C--CgA HIP (HIP9) 在人类1型糖尿病中的相关性的直接证据.
- 表明非风险的HLA单体类型可能通过HIP9识别促进β细胞自身免疫.
- 突出了HIP9作为一种潜在的目标,以了解和干预1型糖尿病的发病过程.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
382
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
382
Glucagon-like Receptor Agonists
323
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
323
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K


